We have located links that may give you full text access.
Localized gastroesophageal adenocarcinoma in the elderly: is age a factor associated with suboptimal treatment?
Oncology 2022 November 22
INTRODUCTION: Gastroesophageal adenocarcinoma is relatively common in elderly patients as the incidence increases with age. However, the optimal treatment approach is not well established in this group of patients. The aim of this study is to review our experience for localized gastroesophageal adenocarcinoma in patients aged ≥ 80 years and to assess association between patient characteristics, clinical factors and overall survival in order to optimize the therapeutic approaches for this population.
METHODS AND MATERIALS: patients ≥ 80 years old treated for localized gastroesophageal adenocarcinoma were retrospectively analyzed. Survival curves were estimated using the Kaplan-Meier method. Univariate and multivariate Cox proportional hazards regression models were applied to assess the association between patient characteristics and overall survival (OS). Factors that were significant in the multivariate model were included in the final reduced model.
RESULTS: 127 patients ≥ 80 years old, were included in this study with median age of 83 years. The median follow-up time was 3.2 years, and median OS was 2.5 years (95% CI: 2.0-3.1 years). Independent prognostic factors for OS were Eastern Cooperative Oncology Group (ECOG) performance status (PS) (p=0.003), baseline clinical stage (p=0.01), and surgery (p=0.001). ECOG PS, tumor location, baseline stage, tumor grade and surgery were included in the final reduced model.
CONCLUSION: Surgical treatment, can improve survival in elderly patients. Therapeutic decisions should be based on the patients' general condition rather that age alone.
METHODS AND MATERIALS: patients ≥ 80 years old treated for localized gastroesophageal adenocarcinoma were retrospectively analyzed. Survival curves were estimated using the Kaplan-Meier method. Univariate and multivariate Cox proportional hazards regression models were applied to assess the association between patient characteristics and overall survival (OS). Factors that were significant in the multivariate model were included in the final reduced model.
RESULTS: 127 patients ≥ 80 years old, were included in this study with median age of 83 years. The median follow-up time was 3.2 years, and median OS was 2.5 years (95% CI: 2.0-3.1 years). Independent prognostic factors for OS were Eastern Cooperative Oncology Group (ECOG) performance status (PS) (p=0.003), baseline clinical stage (p=0.01), and surgery (p=0.001). ECOG PS, tumor location, baseline stage, tumor grade and surgery were included in the final reduced model.
CONCLUSION: Surgical treatment, can improve survival in elderly patients. Therapeutic decisions should be based on the patients' general condition rather that age alone.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app